Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin
- PMID: 2211616
Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin
Abstract
The functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin was studied by functional assessment of cofactor activity and Western blotting analyses of platelet releasates, obtained by stimulating washed suspensions of platelets with various agonists, including collagen, collagen with ADP, and the calcium ionophore A23187. Platelet factor V was released as a partially proteolyzed molecule that was bound to platelet microparticles, irrespective of the agonist used. Radiolabeled plasma factor V was not cleaved for up to 30 min following release when added to platelets prior to stimulation, suggesting that platelet factor V was stored in a partially proteolyzed form. Released platelet factor V possessed significant cofactor activity that was increased only 2-3-fold by either factor Xa or thrombin. The factor V subunits that expressed cofactor activity were isolated and found to consist of peptides of Mr = 220,000 and 150,000. Incubation of released platelet factor V with factor Xa or thrombin yielded the same cleavage pattern, in which two peptides of Mr = 105,000 and 74,000 appeared to be electrophoretically indistinguishable from thrombin-activated plasma factor V. Under the conditions of these studies, factor Xa activated platelet-released factor V 50-100 times more effectively than thrombin. This observation may be due in part to the existence of platelet factor V in a partially proteolyzed state, or its association with platelet microparticles following platelet stimulation. These data collectively suggest that platelet-released factor V may be the foremost initiator of prothrombinase complex assembly and function during the early stages of coagulation with additional cofactor activation accomplished by factor Xa.
Similar articles
-
Activation of human factor V by factor Xa and thrombin.Biochemistry. 1990 Feb 6;29(5):1118-28. doi: 10.1021/bi00457a004. Biochemistry. 1990. PMID: 2322551
-
Human prothrombinase complex assembly and function on isolated peripheral blood cell populations.J Biol Chem. 1985 Feb 25;260(4):2119-24. J Biol Chem. 1985. PMID: 3972783
-
Collagen derived octapeptide inhibits platelet procoagulant activity induced by the combined action of collagen and thrombin.Thromb Res. 1985 Feb 1;37(3):365-70. doi: 10.1016/0049-3848(85)90065-9. Thromb Res. 1985. PMID: 3922080
-
Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.Biochemistry. 1998 Aug 25;37(34):11896-906. doi: 10.1021/bi980520v. Biochemistry. 1998. PMID: 9718313
-
Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles.Blood. 1991 Jun 15;77(12):2641-8. Blood. 1991. PMID: 2043766
Cited by
-
Immunothrombosis and the Role of Platelets in Venous Thromboembolic Diseases.Int J Mol Sci. 2022 Oct 29;23(21):13176. doi: 10.3390/ijms232113176. Int J Mol Sci. 2022. PMID: 36361963 Free PMC article. Review.
-
Factor V, tissue factor pathway inhibitor, and east Texas bleeding disorder.J Clin Invest. 2013 Sep;123(9):3710-2. doi: 10.1172/JCI71220. Epub 2013 Aug 27. J Clin Invest. 2013. PMID: 23979154 Free PMC article.
-
The pro-coagulant fibrinogenolytic serine protease isoenzymes purified from Daboia russelii russelii venom coagulate the blood through factor V activation: role of glycosylation on enzymatic activity.PLoS One. 2014 Feb 10;9(2):e86823. doi: 10.1371/journal.pone.0086823. eCollection 2014. PLoS One. 2014. PMID: 24520323 Free PMC article.
-
Genome-Wide Search for Nonadditive Allele Effects Identifies PSKH2 as Involved in the Variability of Factor V Activity.J Am Heart Assoc. 2024 Nov 5;13(21):e034943. doi: 10.1161/JAHA.124.034943. Epub 2024 Oct 18. J Am Heart Assoc. 2024. PMID: 39424413 Free PMC article.
-
Studying the Effects of Oral Contraceptives on Coagulation Using a Mathematical Modeling Approach.Math Model Womens Health (2024). 2024;155:83-132. doi: 10.1007/978-3-031-58516-6_4. Epub 2024 Mar 28. Math Model Womens Health (2024). 2024. PMID: 40831646 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources